VolitionRx Ltd
VNRX
26 hedge funds and large institutions have $9.9M invested in VolitionRx Ltd in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
99% more capital invested
Capital invested by funds: $4.99M → $9.9M (+$4.91M)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
4% more funds holding
Funds holding: 25 → 26 (+1)
0.01% more ownership
Funds ownership: 0.39% → 0.4% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$719K |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$69.2K |
| 3 |
Charles Schwab
San Francisco,
California
|
+$42.9K |
| 4 |
Renaissance Technologies
New York
|
+$31.8K |
| 5 |
VF
Virtu Financial
New York
|
+$30.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$53K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.75K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 4 |
Bank of New York Mellon
New York
|
-$2.62K |
| 5 |
CPA
Cowen Prime Advisors
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $5K | -$4.75K | -85 | -51% |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$53K | -1,470 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$3K | -89 | Closed |
|
|
CPA
29
Cowen Prime Advisors
New York
| – | -$2K | -51 | Closed |
|
VNRX Hedge Fund Activity: Q1 2019 in Review
26 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2019, worth a combined $9.9M — up 99% from $4.99M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VNRX positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $719K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $53K sold.
- 26 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2019, up from 25 in Q4 2018.
- Funds reported $9.9M of VolitionRx Ltd stock for Q1 2019, up 99% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q1 2019 and 3 closed out, a net change of +1 holder.
- The largest VolitionRx Ltd buyer in Q1 2019 was Lagoda Investment Management, an estimated $719K added.
- The largest VolitionRx Ltd seller in Q1 2019 was Susquehanna International Group, an estimated $53K sold.
Based on aggregated 13F filings for Q1 2019.